Latest Cancer treatments Stories
Selective RORgamma agonist product candidates demonstrated activity as single agent therapy NEW YORK and ANN ARBOR, Mich., Feb.
Nation’s largest cancer magazine reports on beloved television host’s experiences, guidance for others. Plainsboro, NJ (PRWEB) February 05, 2015
LUGANO, Switzerland and COPENHAGEN, Denmark, February 5, 2015 /PRNewswire/ -- - Elsiglutide is a GLP-2 receptor agonist with potential as a first-ever therapy to help cancer
New guidebook helps patients, doctors come together to make most of available treatment options. MADISON, Wisc.
ImmunoDiet treats cancer with nutrition based on genetic data. Houston, Texas (PRWEB) February 03, 2015 Personal Peptides, a provider of precision medicine
New treatment technique developed in partnership with Cancer Immune Biologics ATLANTA, Feb.
USPTO awards patent for combination use of modified citrus pectin and honokiol extract, with potential to inhibit growth of numerous types of cancer SANTA ROSA, Calif., Feb.
A new protein-based treatment could help treat acute lymphoblastic leukemia (ALL) patients whose cancer cells have developed resistance to contemporary chemotherapy, according to new research published online Monday in the Journal of Clinical Investigation.
Study to test drug designed to help patient in late stages of disease GILBERT, Ariz., Jan.
- A person in a secondary role, specifically the second most important character (after the protagonist).
More Images (3 images) »